Thus , we aimed to assess correlations of VEGFR-3 and CXCR4 expression levels with clinical outcome in a randomized phase III study of patients with oxaliplatin/leucovorin/5-FU ( FLO ) versus cisplatin/leucovorin/5-FU ( FLP ) .